TGF-β signaling in vascular biology and dysfunction

被引:447
作者
Goumans, Marie-Jose [1 ,2 ]
Liu, Zhen [1 ,2 ]
ten Dijke, Peter [1 ,2 ]
机构
[1] Leiden Univ, Med Ctr, Dept Mol Cell Biol, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Ctr Biomed Genet, NL-2300 RC Leiden, Netherlands
关键词
angiogenesis; BMP; Marfan syndrome; Smad; pre-eclampsia; pulmonary hypertension; TGF-beta; TRANSFORMING-GROWTH-FACTOR; SMOOTH-MUSCLE-CELLS; HEREDITARY HEMORRHAGIC TELANGIECTASIA; BONE MORPHOGENETIC PROTEIN; PULMONARY ARTERIAL-HYPERTENSION; RECEPTOR-LIKE KINASE-1; ENDOGLIN HETEROZYGOUS MICE; ENDOTHELIAL-CELLS; II RECEPTOR; GENE-EXPRESSION;
D O I
10.1038/cr.2008.326
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Transforming growth factor (TGF)-beta family members are multifunctional cytokines that elicit their effects on cells, including endothelial and mural cells, via specific type I and type II serine/threonine kinase receptors and intracellular Smad transcription factors. Knock-out mouse models for TGF-beta family signaling pathway components have revealed their critical importance in proper yolk sac angiogenesis. Genetic studies in humans have linked mutations in these signaling components to specific cardiovascular syndromes such as hereditary hemorrhagic telangiectasia, primary pulmonary hypertension and Marfan syndrome. In this review, we present recent advances in our understanding of the role of TGF-beta receptor signaling in vascular biology and disease, and discuss how this may be applied therapy.
引用
收藏
页码:116 / 127
页数:12
相关论文
共 119 条
  • [1] Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease
    Abdalla, SA
    Letarte, M
    [J]. JOURNAL OF MEDICAL GENETICS, 2006, 43 (02) : 97 - 110
  • [2] Molecular regulation of angiogenesis and lymphangiogenesis
    Adams, Ralf H.
    Alitalo, Kari
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2007, 8 (06) : 464 - 478
  • [3] Endoglin, an ancillary TGFβ receptor, is required for extraembryonic angiogenesis and plays a key role in heart development
    Arthur, HM
    Ure, J
    Smith, AJH
    Renforth, G
    Wilson, DI
    Torsney, E
    Charlton, R
    Parums, DV
    Jowett, T
    Marchuk, DA
    Burn, J
    Diamond, AG
    [J]. DEVELOPMENTAL BIOLOGY, 2000, 217 (01) : 42 - 53
  • [4] Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor
    Atkinson, C
    Stewart, S
    Upton, PD
    Machado, R
    Thomson, JR
    Trembath, RC
    Morrell, NW
    [J]. CIRCULATION, 2002, 105 (14) : 1672 - 1678
  • [5] Medical therapy for pulmonary arterial hypertension - Updated ACCP evidence-based clinical practice guidelines
    Badesch, David B.
    Abman, Steven H.
    Simonneau, Gerald
    Rubin, Lewis J.
    McLaughlin, Vallerie V.
    [J]. CHEST, 2007, 131 (06) : 1917 - 1928
  • [6] ALK5 and Smad4 are involved in TGF-β1-induced pulmonary endothelial permeability
    Birukova, AA
    Adyshev, D
    Gorshkov, B
    Birukov, KG
    Verin, AD
    [J]. FEBS LETTERS, 2005, 579 (18): : 4031 - 4037
  • [7] Black SM, 2004, P ANN INT IEEE EMBS, V26, P5053
  • [8] Interaction and functional interplay between endoglin and ALK-1, two components of the endothelial transforming growth factor-β receptor complex
    Blanco, FJ
    Santibanez, JF
    Guerrero-Esteo, M
    Langa, C
    Vary, CPH
    Bernabeu, C
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2005, 204 (02) : 574 - 584
  • [9] S-Endoglin Expression Is Induced in Senescent Endothelial Cells and Contributes to Vascular Pathology
    Blanco, Francisco J.
    Grande, Maria T.
    Langa, Carmen
    Oujo, Barbara
    Velasco, Soraya
    Rodriguez-Barbero, Alicia
    Perez-Gomez, Eduardo
    Quintanilla, Miguel
    Lopez-Novoa, Jose M.
    Bernabeu, Carmelo
    [J]. CIRCULATION RESEARCH, 2008, 103 (12) : 1383 - U91
  • [10] Transforming growth factor-βs and vascular disorders
    Bobik, Alex
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (08) : 1712 - 1720